Adaptimmune Therapeutics plc

(ADAP) Trade

By |

Profile

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A10 T-cell therapy, NON-SMALL CELL LUNG CANCER, AFP SPEAR T-cell, MAGE-A4 SPEAR T-cell therapy and NY-ESO SPEAR T-cell for multiple cancer types.

Contact Information

Website: www.adaptimmune.com
Email: IR@adaptimmune.com
Main Phone: +44 1235430000
Address: 60 Jubilee Avenue
Address 2: Milton Park
State: Oxfordshire
City / Town: Abingdon
Country: GBR
Postal Code: OX14 4RY

Issuer Information

Exchange: NGS
CEO: James J. Noble
Employees: 390
NAICS: Pharmaceutical P
$ 5.36 $ 0.11 (2.10%)
Last Price 5.36 Change $ 0.11 Change % 2.10 Tick N/A
Bid 4.64 Bid Size 1,000.00 Ask 7.53 Ask Size 1,200.00
Open 5.29 High 5.36 Low 5.17 Prev Close 5.25
Last Trade Volume 403,053 52 Wk Hi 14.63 52 Wk Low 4.82
Market Cap 560.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 104,570,449.00 EPS (TTM) -0.96 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 16 15 15 16
Standard Deviation 4.69 4.12 4.12 4.69
Date of Most Recent Estimate 06/04/18 05/09/18 05/09/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2 2 2 2